2World Health Organization.Multination monitoring of treads and determinants in cardiovascular disease (MONICA project) and manual of operation.Cardiovascular Disease Unit,Geneva,1993.
3Wilson Peter WF,Agostino RBD,Levy D,et al.Prediction of coronary heart disease using risk factor categories (Framingham),Circulation,1998,97:1837-1847.
4National Cholesterol Education Program (NCEP) Expert Panel on Detection,Evaluation,and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel Ⅲ).Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection,Evaluation,and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel Ⅲ) final report.Circulation,2002,106:3143-3421.
5Leppala JM,Virtamo J,Fogelholm R,et al.Different risk factors for different stroke subtypes:association of blood pressure,cholesterol,and antioxidants.Stroke,1999,30:2535-2540.
6Zhang X,Patel A,Horibe H,et al.Cholesterol,coronary heart disease,and stroke in the Asia Pacific region.Int J Epidemiol,2003,32:563-572.
7Kuulasmaa K,Pedoe TH,Dobson A,et al.Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations.Lancet,2000,355:675-687.
8Eastern Stroke and Coronary Heart Disease Collaborative Research Group.Blood pressure,cholesterol,and stroke in eastern Asia.Lancet,1998,352:1801-1807.
9Verschuren WM,Jacobs DR,Bloemberg BP,et al.Serum total cholesterol and long-term coronary heart disease mortality in different cultures.Twenty-five-year follow-up of the seven countries study.JAMA,1995,274:131-136.
10Critchley J,Liu J,Zhao D,et al.Explaining the increase in coronary heart disease mortality in Beijing 1984 and 1999.Circulation,2004,110:1236-1244.
2Bouderba S.Beneficial effects of silibinin against the pro- gression of metabolic syndrome, increased oxidative stress, and liver steatosis in Psammomys obesus, a rele- vant animal model of human obesity and diabetes [J]. Journal of diabetes,2014. 6(2) : 184-192.
3Reaven, G.M.Insulin resistance: the link between obesity and cardiovascular disease [J]. Medical Clinics of North America, 2011.95 (5) : 875 -892.
4Chen C., F. Lu. The guidelines for prevention and control of overweight and obesity in Chinese adults [J ].Biomedical and environmental sciences: BES, 2004.17 : 1.
5Expert Panel on Detection, E. Executive summary of the third report of the National Cholesterol Education Program(NCEP) expert panel on Detection, Evaluation, and Treatment of high blood cholesterol in adults (Adult Treat- ment Panel III) [J]. Jama, 2001,285( 19): 2486.
6Wang, H.,F. Zhai. Programme and policy options for pre- venting obesity in China[J]. Obesity Reviews, 2013,14( 2 ) : 134-140.
7Bastien M. Overview of epidemiology and contribution of obesity to cardiovascular disease[J]Progressin cardiovas- cular diseases, 2014,56(4) : 369-381.
